HEADER LIPID BINDING PROTEIN 14-DEC-15 5FB7 TITLE LIGAND BINDING DOMAIN 2 OF PENICILLIUM MARNEFFEI MP1 PROTEIN COMPLEXED TITLE 2 WITH MULTIPLE ARACHIDONIC ACIDS COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE GLYCOPROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 188-342; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TALAROMYCES MARNEFFEI PM1; SOURCE 3 ORGANISM_TAXID: 1077442; SOURCE 4 GENE: GQ26_0022220; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: HIS-SUMO KEYWDS LIGAND BINDING DOMAIN 2, MULTIPLE ARACHIDONIC ACIDS, LIPID BINDING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR W.H.LAM,H.ZHANG,Q.HAO REVDAT 4 08-NOV-23 5FB7 1 REMARK REVDAT 3 08-MAR-17 5FB7 1 JRNL REVDAT 2 01-FEB-17 5FB7 1 JRNL REVDAT 1 14-DEC-16 5FB7 0 JRNL AUTH K.H.SZE,W.H.LAM,H.ZHANG,Y.H.KE,M.K.TSE,P.C.WOO,S.K.LAU, JRNL AUTH 2 C.C.LAU,J.P.CAI,E.T.TUNG,R.K.LO,S.XU,R.Y.KAO,Q.HAO,K.Y.YUEN JRNL TITL TALAROMYCES MARNEFFEI MP1P IS A VIRULENCE FACTOR THAT BINDS JRNL TITL 2 AND SEQUESTERS A KEY PROINFLAMMATORY LIPID TO DAMPEN HOST JRNL TITL 3 INNATE IMMUNE RESPONSE JRNL REF CELL CHEM BIOL V. 24 182 2017 JRNL REFN ESSN 2451-9456 JRNL PMID 28111099 JRNL DOI 10.1016/J.CHEMBIOL.2016.12.014 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 86037 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4549 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4592 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 176 REMARK 3 SOLVENT ATOMS : 427 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.25000 REMARK 3 B22 (A**2) : -1.55000 REMARK 3 B33 (A**2) : 1.80000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.16000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.084 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.083 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.626 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5FB7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1000216333. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 90586 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.56700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5CSD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, SODIUM ACETATE, AMMONIUM REMARK 280 ACETATE, PH 4.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 29.61950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.24750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 29.61950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 49.24750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 360 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 3 REMARK 465 VAL A 4 REMARK 465 LYS A 5 REMARK 465 ARG A 6 REMARK 465 LYS B 3 REMARK 465 VAL B 4 REMARK 465 LYS B 5 REMARK 465 ARG B 6 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER C 140 O2 ACD C 202 1.92 REMARK 500 OD1 ASP B 53 ND2 ASN D 45 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 30 CD GLU A 30 OE1 0.138 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 43 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLY C 104 11.26 REMARK 500 GLY D 104 10.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD C 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACD D 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5CSD RELATED DB: PDB REMARK 900 5CSD CONTAINS THE SAME PROTEIN BUT WITH ONLY ONE ARACHIDONIC ACID REMARK 900 BOUND REMARK 900 RELATED ID: 5ECF RELATED DB: PDB REMARK 900 RELATED ID: 5E7X RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHORS STATE THAT THE GENEBANK ACCESSION NUMBER KFX52825 IS FOR REMARK 999 THIS SEQUENCE. DBREF1 5FB7 A 3 157 UNP A0A093VKV7_TALMA DBREF2 5FB7 A A0A093VKV7 188 342 DBREF1 5FB7 B 3 157 UNP A0A093VKV7_TALMA DBREF2 5FB7 B A0A093VKV7 188 342 DBREF1 5FB7 C 3 157 UNP A0A093VKV7_TALMA DBREF2 5FB7 C A0A093VKV7 188 342 DBREF1 5FB7 D 3 157 UNP A0A093VKV7_TALMA DBREF2 5FB7 D A0A093VKV7 188 342 SEQRES 1 A 155 LYS VAL LYS ARG ASP ILE SER ALA PHE GLN LYS VAL ILE SEQRES 2 A 155 GLN ASP ILE SER LEU ALA VAL ASN LYS PHE ASN VAL ASP SEQRES 3 A 155 ILE GLU ARG TYR VAL GLY GLY ASP ALA SER HIS LEU LEU SEQRES 4 A 155 ALA ASP GLY ASN VAL LEU ILE LYS ALA THR LEU ASP GLY SEQRES 5 A 155 VAL GLN SER LEU GLN ASN GLU PRO PRO LEU SER SER MET SEQRES 6 A 155 GLU ALA LEU ALA LEU VAL GLY PRO VAL GLN ASP LEU SER SEQRES 7 A 155 ASN GLN ILE LEU LEU ALA ILE GLN ASN LEU ILE ASP LYS SEQRES 8 A 155 LYS GLU PRO LEU VAL GLN ALA GLY PHE GLY GLY LYS VAL SEQRES 9 A 155 GLU ASN ASN LEU ARG GLN GLN GLU GLU ALA ALA GLN LYS SEQRES 10 A 155 LEU SER GLU LEU VAL SER THR LYS VAL PRO HIS GLU LEU SEQRES 11 A 155 ALA ASP ILE SER ARG GLN LEU SER ASP GLY ILE ALA ALA SEQRES 12 A 155 GLY ILE LYS LYS GLY ILE ASP ALA PHE ALA GLY THR SEQRES 1 B 155 LYS VAL LYS ARG ASP ILE SER ALA PHE GLN LYS VAL ILE SEQRES 2 B 155 GLN ASP ILE SER LEU ALA VAL ASN LYS PHE ASN VAL ASP SEQRES 3 B 155 ILE GLU ARG TYR VAL GLY GLY ASP ALA SER HIS LEU LEU SEQRES 4 B 155 ALA ASP GLY ASN VAL LEU ILE LYS ALA THR LEU ASP GLY SEQRES 5 B 155 VAL GLN SER LEU GLN ASN GLU PRO PRO LEU SER SER MET SEQRES 6 B 155 GLU ALA LEU ALA LEU VAL GLY PRO VAL GLN ASP LEU SER SEQRES 7 B 155 ASN GLN ILE LEU LEU ALA ILE GLN ASN LEU ILE ASP LYS SEQRES 8 B 155 LYS GLU PRO LEU VAL GLN ALA GLY PHE GLY GLY LYS VAL SEQRES 9 B 155 GLU ASN ASN LEU ARG GLN GLN GLU GLU ALA ALA GLN LYS SEQRES 10 B 155 LEU SER GLU LEU VAL SER THR LYS VAL PRO HIS GLU LEU SEQRES 11 B 155 ALA ASP ILE SER ARG GLN LEU SER ASP GLY ILE ALA ALA SEQRES 12 B 155 GLY ILE LYS LYS GLY ILE ASP ALA PHE ALA GLY THR SEQRES 1 C 155 LYS VAL LYS ARG ASP ILE SER ALA PHE GLN LYS VAL ILE SEQRES 2 C 155 GLN ASP ILE SER LEU ALA VAL ASN LYS PHE ASN VAL ASP SEQRES 3 C 155 ILE GLU ARG TYR VAL GLY GLY ASP ALA SER HIS LEU LEU SEQRES 4 C 155 ALA ASP GLY ASN VAL LEU ILE LYS ALA THR LEU ASP GLY SEQRES 5 C 155 VAL GLN SER LEU GLN ASN GLU PRO PRO LEU SER SER MET SEQRES 6 C 155 GLU ALA LEU ALA LEU VAL GLY PRO VAL GLN ASP LEU SER SEQRES 7 C 155 ASN GLN ILE LEU LEU ALA ILE GLN ASN LEU ILE ASP LYS SEQRES 8 C 155 LYS GLU PRO LEU VAL GLN ALA GLY PHE GLY GLY LYS VAL SEQRES 9 C 155 GLU ASN ASN LEU ARG GLN GLN GLU GLU ALA ALA GLN LYS SEQRES 10 C 155 LEU SER GLU LEU VAL SER THR LYS VAL PRO HIS GLU LEU SEQRES 11 C 155 ALA ASP ILE SER ARG GLN LEU SER ASP GLY ILE ALA ALA SEQRES 12 C 155 GLY ILE LYS LYS GLY ILE ASP ALA PHE ALA GLY THR SEQRES 1 D 155 LYS VAL LYS ARG ASP ILE SER ALA PHE GLN LYS VAL ILE SEQRES 2 D 155 GLN ASP ILE SER LEU ALA VAL ASN LYS PHE ASN VAL ASP SEQRES 3 D 155 ILE GLU ARG TYR VAL GLY GLY ASP ALA SER HIS LEU LEU SEQRES 4 D 155 ALA ASP GLY ASN VAL LEU ILE LYS ALA THR LEU ASP GLY SEQRES 5 D 155 VAL GLN SER LEU GLN ASN GLU PRO PRO LEU SER SER MET SEQRES 6 D 155 GLU ALA LEU ALA LEU VAL GLY PRO VAL GLN ASP LEU SER SEQRES 7 D 155 ASN GLN ILE LEU LEU ALA ILE GLN ASN LEU ILE ASP LYS SEQRES 8 D 155 LYS GLU PRO LEU VAL GLN ALA GLY PHE GLY GLY LYS VAL SEQRES 9 D 155 GLU ASN ASN LEU ARG GLN GLN GLU GLU ALA ALA GLN LYS SEQRES 10 D 155 LEU SER GLU LEU VAL SER THR LYS VAL PRO HIS GLU LEU SEQRES 11 D 155 ALA ASP ILE SER ARG GLN LEU SER ASP GLY ILE ALA ALA SEQRES 12 D 155 GLY ILE LYS LYS GLY ILE ASP ALA PHE ALA GLY THR HET ACD A 201 22 HET ACD A 202 22 HET ACD B 201 22 HET ACD B 202 22 HET ACD C 201 22 HET ACD C 202 22 HET ACD D 301 22 HET ACD D 302 22 HETNAM ACD ARACHIDONIC ACID FORMUL 5 ACD 8(C20 H32 O2) FORMUL 13 HOH *427(H2 O) HELIX 1 AA1 ILE A 8 TYR A 32 1 25 HELIX 2 AA2 ALA A 37 GLN A 59 1 23 HELIX 3 AA3 SER A 65 LYS A 93 1 29 HELIX 4 AA4 LYS A 93 ALA A 100 1 8 HELIX 5 AA5 PHE A 102 THR A 126 1 25 HELIX 6 AA6 PRO A 129 GLU A 131 5 3 HELIX 7 AA7 LEU A 132 ALA A 155 1 24 HELIX 8 AA8 ILE B 8 TYR B 32 1 25 HELIX 9 AA9 ALA B 37 GLN B 59 1 23 HELIX 10 AB1 SER B 65 ALA B 71 1 7 HELIX 11 AB2 LEU B 72 LYS B 93 1 22 HELIX 12 AB3 LYS B 93 ALA B 100 1 8 HELIX 13 AB4 PHE B 102 THR B 126 1 25 HELIX 14 AB5 PRO B 129 GLU B 131 5 3 HELIX 15 AB6 LEU B 132 ALA B 155 1 24 HELIX 16 AB7 ILE C 8 TYR C 32 1 25 HELIX 17 AB8 ALA C 37 GLN C 59 1 23 HELIX 18 AB9 SER C 65 LYS C 93 1 29 HELIX 19 AC1 LYS C 93 ALA C 100 1 8 HELIX 20 AC2 PHE C 102 THR C 126 1 25 HELIX 21 AC3 PRO C 129 GLU C 131 5 3 HELIX 22 AC4 LEU C 132 ALA C 155 1 24 HELIX 23 AC5 ILE D 8 TYR D 32 1 25 HELIX 24 AC6 ALA D 37 GLN D 59 1 23 HELIX 25 AC7 SER D 65 LYS D 93 1 29 HELIX 26 AC8 LYS D 93 ALA D 100 1 8 HELIX 27 AC9 PHE D 102 THR D 126 1 25 HELIX 28 AD1 PRO D 129 GLU D 131 5 3 HELIX 29 AD2 LEU D 132 ALA D 155 1 24 SITE 1 AC1 11 LEU A 47 THR A 51 ILE A 83 ASN A 109 SITE 2 AC1 11 GLN A 113 ALA A 117 SER A 121 SER A 140 SITE 3 AC1 11 ILE A 147 ACD A 202 HOH A 316 SITE 1 AC2 9 VAL A 76 LEU A 79 VAL A 124 ILE A 135 SITE 2 AC2 9 SER A 136 LEU A 139 SER A 140 ACD A 201 SITE 3 AC2 9 LEU C 70 SITE 1 AC3 11 LEU B 47 THR B 51 ILE B 83 ASN B 109 SITE 2 AC3 11 GLN B 113 ALA B 117 SER B 121 SER B 140 SITE 3 AC3 11 ILE B 147 ACD B 202 HOH B 352 SITE 1 AC4 8 PHE B 11 VAL B 76 LEU B 79 VAL B 124 SITE 2 AC4 8 SER B 136 LEU B 139 SER B 140 ACD B 201 SITE 1 AC5 13 PHE C 25 LEU C 40 LEU C 47 THR C 51 SITE 2 AC5 13 ILE C 83 ASN C 109 GLN C 113 ALA C 117 SITE 3 AC5 13 SER C 121 VAL C 124 SER C 140 ACD C 202 SITE 4 AC5 13 HOH C 366 SITE 1 AC6 12 VAL C 14 ILE C 15 ALA C 69 LEU C 72 SITE 2 AC6 12 VAL C 73 VAL C 76 VAL C 124 SER C 136 SITE 3 AC6 12 LEU C 139 SER C 140 ACD C 201 HOH C 347 SITE 1 AC7 11 PHE D 25 LEU D 47 ASN D 109 LEU D 110 SITE 2 AC7 11 GLN D 113 ALA D 117 SER D 121 SER D 140 SITE 3 AC7 11 ILE D 147 ACD D 302 HOH D 459 SITE 1 AC8 12 PHE D 11 VAL D 14 ILE D 15 ALA D 69 SITE 2 AC8 12 VAL D 73 VAL D 76 VAL D 124 SER D 136 SITE 3 AC8 12 LEU D 139 SER D 140 ACD D 301 HOH D 454 CRYST1 59.239 98.495 100.120 90.00 90.01 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016881 0.000000 0.000004 0.00000 SCALE2 0.000000 0.010153 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009988 0.00000